Typical criteria: BMI 30 (or 27 with hypertension, type 2 diabetes, sleep apnea, etc.) 3-6 months documented lifestyle efforts (diet and exercise in your medical record) No concurrent GLP-1 use (can't take Ozempic, Wegovy at same time) Step therapy (trying other medications first): Some plans require trying other weight loss drugs before approving Wegovy Renewal: Must show 5% weight loss to continue coverage For complete documentation checklists and PA preparation: Wegovy Prior Authorization Guide Your GLP-1 coverage, denied approved If Anthem denies your Wegovy, Honest Care can help you build a strong appeal with evidence-backed documentation
It is most often studied in animal models of tendon, gut, and vessel injury, and is not an FDA-approved drug
Kelley, A
Regular monitoring of blood sugar and overall health is recommended
Researchers have discovered that GLP-1 and its analogs promote feelings of satiety and reduce food intake in these areas, which explains why individuals taking GLP-1 agonists may experience diminished cravings and fewer binge-eating episodes , contributing to sustainable weight loss over the long term
